Showing results (481-490 of 511) with videos related to

Sort By:
Pageof 52
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective StudySarah Waliany, Shambo Guha Roy, Federica Pecci, et al.
Nature Communications|February 7, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Cancer Discovery|May 3, 2015
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR InhibitorZofia Piotrowska, Matthew J Niederst, Chris A Karlovich, et al.
Research Square|November 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination StrategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
JCO Precision Oncology|April 9, 2026
Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung CancerRika Terashima, Judy Fan, Fatma Gunturkun, et al.
Cancer|October 5, 2023
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group trialsAngela Wangari Walter, Ju-Whei Lee, Joanna M Streck, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 6, 2023
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical TrialsJoanna M Streck, Ju-Whei Lee, Angela Wangari Walter, et al.
Annals of Surgical Oncology|August 8, 2021
Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast CancerKelly M Herremans, Morgan P Cribbin, Andrea N Riner, et al.
NPJ Digital Medicine|November 29, 2025
Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillanceIngrid Luo, Anna Graber-Naidich, Mengrui Zhang, et al.
Cancer Discovery|September 14, 2017
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA ProfilingAadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, et al.
Pageof 52